TB-4/TB-500: Handling, Storage, and Reconstitution Guide

This guide covers laboratory handling, storage, and reconstitution of TB-4/TB-500, full-length thymosin beta-4, as a lyophilized research peptide. Every step below is framed as laboratory best practice for in-vitro and animal-model preparation, not as human-use instruction.

TB-4/TB-500 Handling and Storage Fundamentals

TB-4/TB-500 ships as a solid, white lyophilized powder in a sealed glass vial. Store the lyophilized material at or below 25 degrees Celsius, sealed, and protected from heat, light, and moisture. For extended storage, keep it lyophilized and refrigerated or frozen. As a large 43-residue peptide, it benefits from careful cold-chain discipline to preserve integrity.

Puritide supplies TB-4/TB-500 in a 20 mg vial, so working-stock concentration follows from the diluent volume chosen for that mass.

Working with a 43-residue protein places a premium on gentle preparation and stable storage, since larger peptides are more susceptible to shear and to degradation across thermal cycles. Careful reconstitution and disciplined aliquoting are correspondingly more important for preserving the intact molecule's integrity. Planning aliquot sizes around a study's expected use also matters for a 20 mg vial, since thawing only what each experiment needs protects the remaining material and keeps actin and angiogenesis readouts comparable across a long series of assays.

Confirm Identity Before Use

Verify the material against its documentation: molecular formula C212H350N56O78S, molecular weight approximately 4963.44 g/mol, and CAS number 77591-33-4, with synonyms including thymosin beta-4. Matching these to the certificate of analysis is the first traceability checkpoint and anchors the actin and angiogenesis assays in the TB-4/TB-500 mechanism of action.

Reconstitution for In-Vitro Preparation

Reconstitute lyophilized TB-4/TB-500 with bacteriostatic water or another solvent appropriate to the assay. Add the diluent slowly down the inner wall of the vial rather than onto the powder, and allow the peptide to dissolve gently. Swirl; avoid vortexing aggressively or shaking, which can shear the peptide.

• Introduce diluent against the vial wall, not onto the pellet.
• Allow gentle, complete dissolution of this larger peptide.
• Inspect the solution before use.
• Compute concentration from labeled mass and diluent volume.

Aliquoting to Limit Freeze-Thaw

Divide reconstituted TB-4/TB-500 into single-use aliquots so each experiment draws from a vial thawed only once. Label each aliquot with compound name, concentration, date, and lot number. Minimizing freeze-thaw cycles keeps the actin and repair readouts in the TB-4/TB-500 research applications comparable across replicates, in line with the TB-500 handling guide.

Cold-Chain and Working-Solution Storage

Store reconstituted aliquots frozen for longer holds, and keep short-term working solutions cold and protected from light. Maintain consistent conditions throughout the study period and monitor storage records as part of quality assurance. Documenting time-at-temperature supports reproducibility and audit readiness, mirroring the BPC/TB500 blend handling guide where a related fragment appears.

COA and Lot Verification

Each TB-4/TB-500 batch ships with a third-party-verified certificate of analysis documenting purity (HPLC / reverse-phase chromatography), mass-spectrometry identity confirmation, and lot, testing date, and method details. Verify the COA against the vial label and retain it with your batch records. Sample COAs can be requested ahead of purchase.

PPE and Institutional Compliance

Handle TB-4/TB-500 as an investigational material. Follow institutional SOPs, chemical hygiene plans, and approved protocols; wear a lab coat, gloves, and eye protection; and use engineering controls where required. All handling should be performed by qualified personnel in controlled environments. Specifications are on the TB-4/TB-500 product page.

At intake, match the vial to its recorded synonyms and confirm the expected white lyophilized appearance, taking care to record that the material is the full-length 43-residue protein rather than the fragment. For a large peptide used in comparative designs, this clarity at receipt prevents the protein and its fragment from being conflated later.

Traceability for a Large Peptide

As a large 43-residue protein, TB-4/TB-500 rewards careful documentation of the conditions that preserve its integrity. A complete record links the lot number and certificate of analysis to the reconstitution solvent, the final concentration, and each aliquot's storage temperature and freeze-thaw count, so the material behind an actin or angiogenesis readout can be reconstructed precisely.

Where a study compares the full-length protein against its fragment, the documentation should make the distinction unmistakable, recording which material was used in each arm. This prevents the full protein and the fragment from being conflated later and keeps fragment-versus-full-length comparisons interpretable across the study period.

Consistent handling is ultimately a reproducibility measure. A TB-4/TB-500 preparation that is verified against its certificate of analysis, reconstituted gently, aliquoted to limit freeze-thaw, stored under stable cold-chain conditions, and fully documented gives every downstream experiment the same reliable starting material. That consistency is what allows independent laboratories to compare results and build on one another's work with confidence. When a study later proves difficult to reproduce, a complete handling record is often what lets investigators distinguish a genuine biological difference from a preparation artifact, which is why the effort invested in disciplined TB-4/TB-500 handling repays itself throughout a project.

For research use only. These handling notes describe laboratory practice for TB-4/TB-500 as a research material supplied by Puritide Research. It is not approved for human or veterinary use, and nothing here constitutes medical or administration guidance.